Study shows rising rates of NET incidence, prevalence and survival

download

A long awaited epidemiological study just published in JAMA Oncology shows progress in the early detection of NETs and improvements in overall survival in the U.S. over many decades.

Check it out here:      Study from Neuroendocrine Tumor Research Foundation

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

Bringing Together Experts to Improve NET Patient Care: NECA at the 5th NET Preceptorship

NECA at ENETS 2025: Advancing NET Care on the Global Stage

The Australian Cancer Plan

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness

Walk, run, or ride this March4NETs!

For its third year, March4NETs will run throughout March 2026.

Get involved and support the 31,000 Australians living with neuroendocrine cancer.